EcoDrugPlus

Tubulin, Beta 5

Ensembl ID : ENSDLAG00005033850
Gene Symbol: TUBB5
1 Cross references
114 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSDLAG00005015404
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSDLAG00005012407
Gene Symbol: TYR
1 Cross references
203 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSDLAG00005005156
Gene Symbol: TH
1 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSDLAG00005020950
Gene Symbol: TYK2
1 Cross references
196 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSDLAG00005005149
Gene Symbol: UTS2R
1 Cross references
92 Possible Orthologues:

V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog

Ensembl ID : ENSDLAG00005027896
Gene Symbol: KRAS
1 Cross references
208 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2

Ensembl ID : ENSDLAG00005007437
Gene Symbol: AKT2
1 Cross references
199 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2, Like

Ensembl ID : ENSDLAG00005006920
Gene Symbol: AKT2L
1 Cross references
185 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 3a

Ensembl ID : ENSDLAG00005022766
Gene Symbol: AKT3A
1 Cross references
203 Possible Orthologues:

V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A

Ensembl ID : ENSDLAG00005030281
Gene Symbol: RELA
1 Cross references
201 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSDLAG00005029427
Gene Symbol: VEGFAB
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).